Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04458181 · ClinicalTrials.gov registry record · NA
Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"
A NA study of Addiction, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT04458181: Completed NA study of Addiction, sponsored by University of Minnesota.
NCT04458181 is a NA study of Addiction that has completed, run by University of Minnesota. The registered enrollment target is 81 participants, below the 688-participant average among 16 other Addiction trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04458181, a NA study of Addiction, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed "Positive Recovery Journaling" (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.
Primary Outcome
Score on the "Satisfaction with Life" scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Conditions Studied
Interventions
- BEHAVIORAL Positive Peer Journaling (PPJ)
Study Locations (1)
Minnesota
- NUWAY - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT04458181 record still lists
NCT04458181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 688-participant average among 16 other Addiction trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Addiction appearing as the primary indexed condition, and to 1 intervention - of which Positive Peer Journaling (PPJ) is the first listed.
NCT04458181 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04458181 about?
NCT04458181 is a clinical study titled "Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"". The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed "Positive Recovery Journaling" (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control ...
What is the current status of trial NCT04458181?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2020-07-07. Estimated completion is 2021-11-01.
What conditions does trial NCT04458181 study?
This clinical trial studies the following conditions: Addiction.
What interventions are being tested in trial NCT04458181?
The interventions under investigation include: Positive Peer Journaling (PPJ) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04458181?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04458181 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04458181's enrollment target sits among peer trials
81 10th of 16 higher than 7 of 16 other Addiction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
RECRUITING · NA
-
Behavioral and Functional Task Development, Implementation, and Testing
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
ACTIVE NOT RECRUITING · NA
-
Group Activities to Support Addiction Recovery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI